Hainan Huluwa Pharmaceutical Group Co. Ltd. Class ASSE: 605199

"HAINAN HULUWA PHARMACEUTICAL GROUP CO., LTD."Semi-annual Report for 2026

Aug 27, 2026 · Issued by Hainan Huluwa Pharmaceutical Group Co. Ltd. Class A via Shanghai Stock Exchange

Semi-annual Report for 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Hainan Huluwa Pharmaceutical Group Co. Ltd. Class A

"HAINAN HULUWA PHARMACEUTICAL GROUP CO., LTD."Rectification Report in Response to Warning Letter from Hainan CSRC OfficeAug 15
"HAINAN HULUWA PHARMACEUTICAL GROUP CO., LTD."Announcement on Change of Sponsor Representative for Continuous SupervisionAug 8
"HAINAN HULUWA PHARMACEUTICAL GROUP CO., LTD."Announcement on Obtaining Drug Registration Certificate by the Company and Its Wholly-owned SubsidiaryAug 7
"HAINAN HULUWA PHARMACEUTICAL GROUP CO., LTD."Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026Jul 30

All Hainan Huluwa Pharmaceutical Group Co. Ltd. Class A news releases